Gene Score, Endocrine Response Can Guide Early Breast Cancer Therapy
(MedPage Today) -- Use of the 21-gene recurrence score (RS) combined with response to 3-week preoperative endocrine therapy can be used to guide systemic therapy in early breast cancer patients with limited nodal involvement, and can help avoid...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Cancer Therapy | Endocrine Therapy | Genetics | Hematology